Publications issues du registre REFERCHOL

Referchol

Le REgistre Français des hypERCHOLestérolémies familiales (REFERCHOL) soutenu par la NSFA a permis de générer plusieurs publications scientifiques dans des journaux internationaux à comité de lecture depuis 2016:

SAFEHEART risk-equation and cholesterol-year-score are powerful predictors of cardiovascular events in French patients with familial hypercholesterolemia.
Gallo A, Charriere S, Vimont A, Chapman MJ, Angoulvant D, Boccara F, Cariou B, Carreau V, Carrié A, Bruckert E, Béliard S; French REgistry of Familial hypERCHOLesterolemia (REFERCHOL) investigators.
Atherosclerosis. 2020;306:41-49.
doi: 10.1016/j.atherosclerosis.2020.06.011.
PMID: 32688103

High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia: The French Familial Hypercholesterolemia Registry.
Béliard S, Boccara F, Cariou B, Carrié A, Collet X, Farnier M, Ferrières J, Krempf M, Peretti N, Rabès JP, Varret M, Vimont A, Charrière S, Bruckert E; French FH Registry group.
Atherosclerosis. 2018 Oct;277:334-340.
doi: 10.1016/j.atherosclerosis.2018.08.010.
PMID: 30270068

Overview of the current status of familial hypercholesterolaemia care in over 60 countries – The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).
EAS Familial Hypercholesterolaemia Studies Collaboration, Vallejo-Vaz AJ, De Marco M, Stevens CAT, Akram A, Freiberger T, Hovingh GK, Kastelein JJP, Mata P, Raal FJ, Santos RD, Soran H, Watts GF, Abifadel M, Aguilar-Salinas CA, Al-Khnifsawi M, AlKindi FA, Alnouri F, Alonso R, Al-Rasadi K, Al-Sarraf A, Ashavaid TF, Binder CJ, Bogsrud MP, Bourbon M, Bruckert E, Chlebus K, Corral P, Descamps O, Durst R, Ezhov M, Fras Z, Genest J, Groselj U, Harada-Shiba M, Kayikcioglu M, Lalic K, Lam CSP, Latkovskis G, Laufs U, Liberopoulos E, Lin J, Maher V, Majano N, Marais AD, März W, Mirrakhimov E, Miserez AR, Mitchenko O, Nawawi HM, Nordestgaard BG, Paragh G, Petrulioniene Z, Pojskic B, Postadzhiyan A, Reda A, Reiner Ž, Sadoh WE, Sahebkar A, Shehab A, Shek AB, Stoll M, Su TC, Subramaniam T, Susekov AV, Symeonides P, Tilney M, Tomlinson B, Truong TH, Tselepis AD, Tybjærg-Hansen A, Vázquez-Cárdenas A, Viigimaa M, Vohnout B, Widén E, Yamashita S, Banach M, Gaita D, Jiang L, Nilsson L, Santos LE, Schunkert H, Tokgözoğlu L, Car J, Catapano AL, Ray KK; EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Investigators.
Atherosclerosis. 2018 Oct;277:234-255.
doi: 10.1016/j.atherosclerosis.2018.08.051.
PMID: 30270054

Lipoprotein-apheresis in familial hypercholesterolemia: Long-term patient compliance in a French cohort.
Beliard S, Gallo A, Duchêne E, Carrié A, Bittar R, Chapman MJ, Bruckert E, Saheb S.
Atherosclerosis. 2018 Oct;277:66-71.
doi: 10.1016/j.atherosclerosis.2018.08.007.
PMID: 30176566

Familial hypercholesterolemia: experience from France.
Rabès JP, Béliard S, Carrié A.
Curr Opin Lipidol. 2018 Apr;29(2):65-71.
doi: 10.1097/MOL.0000000000000496. Review.
PMID: 29389714

 

The very high cardiovascular risk in heterozygous familial hypercholesterolemia: Analysis of 734 French patients.
Béliard S, Millier A, Carreau V, Carrié A, Moulin P, Fredenrich A, Farnier M, Luc G, Rosenbaum D, Toumi M, Bruckert E; French FH Registry group.
J Clin Lipidol. 2016 Sep-Oct;10(5):1129-1136.e3.
doi: 10.1016/j.jacl.2016.06.007.
PMID: 27678429